Best Healthcare Stocks To Keep An Eye On – November 9th

Moderna, Eli Lilly and Company, and UnitedHealth Group are the three Healthcare stocks to watch today, according to MarketBeat’s stock screener tool. Healthcare stocks are shares of publicly traded companies that provide healthcare-related products or services, such as pharmaceuticals, biotechnology, medical devices, hospitals, and health insurance. For investors, they offer exposure to the healthcare sector, with returns influenced by factors such as medical innovation, regulation, and demand for care. These companies had the highest dollar trading volume of any Healthcare stocks within the last several days.

Moderna (MRNA)

Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, autoimmune, and cardiovascular diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, influenza, and respiratory syncytial virus, spikevax, and hMPV/PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella zoster virus, and human immunodeficiency virus vaccines; public health vaccines consists of Zika, Nipah, Mpox vaccines; and infectious diseases vaccines, such as lyme and norovirus vaccines.

Shares of MRNA stock traded up $23.60 during trading on Monday, hitting $277.79. The company’s stock had a trading volume of 6,939,586 shares, compared to its average volume of 12,623,705. The company has a current ratio of 3.62, a quick ratio of 3.47 and a debt-to-equity ratio of 0.52. The company has a market cap of $110.90 billion, a PE ratio of -39.15 and a beta of 1.16. The business has a fifty day moving average of $191.85 and a 200-day moving average of $91.51. Moderna has a 52 week low of $22.28 and a 52 week high of $280.54.

Eli Lilly and Company (LLY)

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity.

Eli Lilly and Company stock traded up $49.93 during mid-day trading on Monday, reaching $1,403.93. 1,281,247 shares of the company’s stock were exchanged, compared to its average volume of 2,955,723. The business’s fifty day simple moving average is $1,215.24 and its 200 day simple moving average is $1,101.16. The firm has a market capitalization of $1.32 trillion, a PE ratio of 45.55, a P/E/G ratio of 1.62 and a beta of 0.40. Eli Lilly and Company has a one year low of $850.51 and a one year high of $1,453.00. The company has a quick ratio of 1.00, a current ratio of 1.39 and a debt-to-equity ratio of 1.17.

UnitedHealth Group (UNH)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

NYSE:UNH traded up $3.96 during trading on Monday, reaching $398.12. The company’s stock had a trading volume of 1,724,852 shares, compared to its average volume of 7,216,657. UnitedHealth Group has a 12 month low of $255.96 and a 12 month high of $461.62. The firm has a market cap of $356.72 billion, a price-to-earnings ratio of 22.76, a price-to-earnings-growth ratio of 1.43 and a beta of 0.51. The firm has a 50 day moving average of $390.62 and a 200-day moving average of $364.03. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.74 and a current ratio of 0.74.